Stock Taper
AZTA
AZENTA, INC.
NASDAQ
$35.89
▼ DOWN 8.79% (-3.46)

KEY STATISTICS

Market Cap$1.65 B
52w High$46.41
52w Low$15.93
Dividend Yield0.37%
FrequencyQuarterly
P/E85.45
Volume1.64M
Shares Out.46.09M

COMPANY

LEADERSHIP

Martin D. Madaus
CHIEF EXECUTIVE
Martin D. Madaus

COMPENSATION 2026

Salary$900,000
Stock Awards$8,386,297
Incentive Plan Pay$1,063,656
All Other Comp.$21,462
Total$10,371,414

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 2, 1995
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
2,900

PRICE TARGET

Target High$45.00
Target Low$38.00
Target Median$44.50
Target Consensus$43.00

UPCOMING EARNINGS

DateNov 20, 2026
DayFriday
Rev. Est.$160.32M
NOV
20
FRI

ETFS HOLDING THIS STOCK

ETFS HOLDING
127
LISTED HERE
10
RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
66.38%
HOLDERS
419
TOP 8 OF 419 · RANKED BY POSITION SIZE

PRICE

$35.89 ▼ DOWN 8.79% (−$3.46)
$36.00$37.00$38.00$39.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM35.89

About Azenta, Inc.

https://www.azenta.com ↗

Azenta, Inc. provides life science sample management solutions—including equipment, services, and integrated cold chain and laboratory support—to research, biotech, and pharma customers worldwide.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT AZENTA, INC. IS KNOWN FOR

BioArc™ Ultra
BioArc™ Ultra

Launched in February 2024, BioArc™ Ultra is an eco-friendly, automated ultracold sample management system for large biorepositories, reducing electricity use by 70% with natural air cooling and zero ozone depletion.

Azenta in 2025

SENTIMENT: + POSITIVE
Luc Provost
ACQUISITION · DECEMBER 29, 2025

Azenta Announces Definitive Agreement to Sell its B Medical Systems Business for $63 Million

Azenta announced it signed a binding agreement to sell its B Medical Systems business, a global manufacturer of medical refrigeration devices, to THELEMA S.À R.L. The deal marks a significant step in Azenta's strategy to simplify its portfolio and focus on core life sciences capabilities.

DIVESTITURE · DECEMBER 2025 · ANNOUNCED

Azenta Divests B Medical Systems to Sharpen Focus on Core Life Sciences Business

Azenta announced a definitive agreement to sell its B Medical Systems business, a manufacturer and global distributor of medical refrigeration devices. This strategic move is intended to simplify the company's portfolio and intensify its focus on driving growth and profitability within its core life sciences operations.

Latest News

NEWSFILE CORP · OCT 7, 2026

ROSEN, A LEADING LAW FIRM, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA

New York, New York--(Newsfile Corp. - October 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

EARLIER COVERAGE
GURUFOCUS · OCT 6, 2026

Azenta Inc (AZTA) Shares Fall 7.9% -- What GF Score of 83 Tells Investors

On October 06, 2026, Azenta Inc (AZTA) shares fell 7.9% today, currently priced at $39.35. This move comes amid a 52-week range of $15.93 to $46.41, reflecting

GLOBENEWSWIRE · OCT 6, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

GLOBENEWSWIRE · OCT 6, 2026

Azenta, Inc. Investor News: If You Have Suffered Losses in Azenta, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigatge potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.

GURUFOCUS · OCT 5, 2026

Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA

Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTAPR NewswireNEW YORK, Oct. 5, 2026NEW YORK, Oct. 5,

NEWSFILE CORP · OCT 4, 2026

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA

New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEWSFILE CORP · OCT 3, 2026

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA

New York, New York--(Newsfile Corp. - October 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEWSFILE CORP · OCT 2, 2026

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA

New York, New York--(Newsfile Corp. - October 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Azenta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book4
Overall Score2

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OUTPERFORM 2
HOLD 1
5 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
TMO$661.59COMPARE
DHR$217.66COMPARE
SOLV$86.63COMPARE
TECH$72.47COMPARE
BIO$372.82COMPARE
BRKR$59.66COMPARE
SYRE$80.99COMPARE
NEOG$11.61COMPARE

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2026-03-03
Gilbert Ray Cisneros
Gilbert Ray Cisneros
Purchase
2026-03-03
Josh Gottheimer
Josh Gottheimer
Sale (Full)
2025-03-19
Josh S. Gottheimer
Josh S. Gottheimer
Sale (Full)
2025-03-19

INSIDER TRADES

★
OFFICER: INTERIM CEO
Madaus Martin D
Sale · 1.5K shares
2026-09-22
★
OFFICER: VP CHIEF ACCOUNTING OFFICER
Bello Erik J.
Purchase · 4.6K shares
2026-09-15
★
OFFICER: SVP, GEN COUNSEL & SECRETARY
Starr Ephraim
Purchase · 15.3K shares
2026-09-14
★
OFFICER: EVP, CFO AND TREASURER
Lin Lawrence Y.
Purchase · 30.5K shares
2026-09-14